Investigating the Association between rs712829 Polymorphism of EGFR Gene with Lung Cancer as a Predictive Marker in Iranian Population

Document Type : Original Article

Authors

1 MSc in Genetic, Infectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran

2 MSc in Genetic, Infectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.

3 PhD of Genetics, Infectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.

10.22118/jsmj.2023.399031.3147

Abstract

Background and Objectives Lung cancer is the leading cause of cancer death globally. The epidermal growth factor receptor (EGFR) plays an important role in cell proliferation and signaling. In this study, we examined the association between EGFR (rs712829) gene polymorphism and lung cancer risk among the Iranian population. Subjects and Methods A total of 100 patients with primary lung cancer and 100 matched healthy controls were recruited into this study. EGFR rs712829 single nucleotide polymorphism (SNP) were genotyped by PCR-RFLP techniques for this association with lung cancer risk. Results A significant association was observed between the GG genotype (P= 0.039, OR= 5.500, CI=95%; 1.710- 11.921) and also G (P= 0.001, OR= 2.967, CI=95%; 1.557- 5.691) allele of rs712829 SNP with lung cancer risk, this was while the TT genotype and T allele of this polymorphism showed a protective role against risk of lung cancer. Conclusion In conclusion, EGFR rs712829 was associated with a risk of lung cancer among Iranians. More studies in other Iranian populations are required to confirm the present findings.

Highlights

Milad Pezeshki [PumMed] [Google Scholar]

Jamshid Ansari [PumMed] [Google Scholar]

 Azam Ahmadi [PumMed] [Google Scholar]

Keywords

Main Subjects

References

[1] Pezeshki M, Ansari J, Esfandyari M, Tamjidi E, Ahmadi A, Komijani D. Investigating the Importance of the Role of Key Genes in the Diagnosis and Treatment of Lung Cancer: A Review Article. Paramedical Sciences and Military Health. 2023 Oct 10;18(1):61-77. [Link] [2] Pezeshki M, Hosseini SM, Ansari J, Ahmadi A. Investigating the importance of Exo1 (K589E) and LEP (− 2548G/A) gene polymorphisms with risk of lung cancer as potential diagnostic biomarker in Iranian population. Egyptian Journal of Medical Human Genetics. 2023 Sep 23;24(1):55. [link]
[3] Grenda A, Błach J, Szczyrek M, Krawczyk P, Nicoś M, Kuźnar Kamińska B, Jakimiec M, Balicka G, Chmielewska I, Batura‐Gabryel H, Sawicki M. Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients. Cancer Medicine. 2020 Jan;9(2):605-14. [10.1002/cam4.2743 ] [PMID]
[4] Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, Enyioha C, Malo TL, Brenner AT, Armstrong C, Coker-Schwimmer M. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. Jama. 2021 Mar 9;325(10):971-87. [10.1001/jama.2021.0377 ] [PMID]
[5] Chetan MR, Gleeson FV. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. European radiology. 2021 Feb;31:1049-58. [10.1007 / s00330-020-07141-9 ] [PMID]
[6] Bab S, Abdifard E, Moradi Y, Faraj A, Heidari M. Lung cancer incidence trends in Iran and in six geographical regions of the country (2000-2005). Shiraz E Medical Journal. 2016;17(6). [Link]
[7] Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. Journal of thoracic oncology. 2015 Sep 1;10(9):1243-60. [10.1097/JTO.0000000000000630 ] [PMID]
[8] Rahal Z, El Nemr S, Sinjab A, Chami H, Tfayli A, Kadara H. Smoking and lung cancer: a geo-regional perspective. Frontiers in oncology. 2017 Sep 1;7:194. [10.3389/fonc.2017.00194 ] [PMID]
[9] Yang IA, Holloway JW, Fong KM. Genetic susceptibility to lung cancer and co-morbidities. Journal of thoracic disease. 2013 Oct;5(Suppl 5):S454. [10.3978/j.issn.2072-1439.2013.08.06 ] [PMID]
[10] Torres-Jasso JH, Marín ME, Santiago-Luna E, Leoner JC, Torres J, Magaña-Torres MT, Perea FJ, Ibarra B, Sánchez-López JY. EGFR gene polymorphisms-216G> T and-191C> A are risk markers for gastric cancer in Mexican population. Genetics and Molecular Research. 2015 Mar 13;14(1):1802-7. [10.4238/ 2015.March.13.8 ] [PMID]
[11] Stoehlmacher-Williams J, Obermann L, Ehninger G, Goekkurt E. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC). Anticancer research. 2012 Feb 1;32(2):421-5. [PMID]
Jundishapur Scientific Medical Journal
Volume 22, Issue 4 - Serial Number 145
September and October 2024
Pages 458-468

Files

History

  • Receive Date: 25 May 2023
  • Revise Date: 26 October 2023
  • Accept Date: 29 November 2023

Share

How to cite

Statistics